Understanding Your ROI

John Elliott from Carevive delves into the pressing question of ROI in the evolving landscape of value-based care reimbursement models. As the oncology care model (OCM) transitions into the enhancing oncology model, stakeholders are evaluating the technology, processes, and resources that will support their future endeavors.

Carevive proves to be a twofold solution, seamlessly aligning with the current fee-for-service model for chronic care management. By providing tools and solutions to manage symptoms, Carevive aids in avoiding hospitalizations and enhancing patient outcomes, leading to additional revenue and reimbursements for partners.

Moreover, Carevive is firmly positioned to align with the future enhanced oncology model, as it focuses on driving transformation, quality metrics, and health equity advancement. The integration of electronic patient-reported outcomes (ePROs) exemplifies Carevive’s commitment to symptom remote management, a vital component of the future model.

Recent Episodes

Emergency departments across the U.S. are under unprecedented strain, with overcrowding, staffing shortages, and inpatient bed constraints converging into a throughput crisis. The American Hospital Association reports that hospital capacity and workforce growth have lagged, intensifying delays from arrival to disposition. At the same time, advances in artificial intelligence are moving from experimental to operational—raising…

Episode 4 of The Future of Patient Monitoring takes a step back from infrastructure and innovation to explore something deeper: the people behind the technology—and what they’ve learned through years of building smarter systems. Part of the Health and Life Sciences at the Edge podcast series, this conversation is led by Intel’s Kaeli Tully,…

As hospitals across the U.S. shorten length of stay and push more recovery into the home, families are increasingly left to manage complex care needs without formal training or support. Roughly one in five patients with chronic conditions like COPD or congestive heart failure is readmitted within 30 days—a cycle that costs the healthcare…